Summary
Background
During the past decades, a steady increase in the incidence of invasive Candida infections in patients requiring intensive care has been reported. Nevertheless, the diagnosis of invasive Candida infections in the intensive care unit setting remains still difficult and is often made late in the course of disease. Additionally, prognosis worsens rapidly with delayed initiation of antifungal therapy. Clinical scoring systems such as the Candida colonization index or the four risk factor-based Candida score could be very useful tools to select patients at high risk of developing invasive Candida infections, who would benefit from the administration of systemic antifungal therapy.
Objectives
The main objective was to determine the incidence of invasive Candida infection among patients of a medical intensive care unit and to investigate its association with the Candida colonization index and the Candida score.
Material and methods
A prospective, observational, single-center study was performed from December 2010 to December 2011. All patients over the age of 18 years who were admitted for at least 7 days in a medical intensive care unit were included. Demographic characteristics, underlying diseases, reasons for intensive care unit admission and presence and duration of risk factors for Candida species colonization and infection were collected for each patient. The Candida colonization index and the Candida score were calculated weekly until discharge or death.
Results
A total of 65 patients were included. Proven invasive Candida infections were diagnosed in five patients (7.7 %), i.e. two developed candidemia, two peritonitis, and one pneumonia. All of these patients were characterized by a Candida colonization index ≥ 0.5 (incidence rate: 16.7 % [5/30]) and a Candida score ≥ 2.5 (incidence rate: 29.4 % [5/17]). Mechanical ventilation (p = 0.013) and both Candida scoring systems (p = 0.013 versus p < 0.001) were statistically and significantly associated with invasive Candida infections. The mortality rate was high (80 %). Interestingly, treatment with antifungal drugs was not statistically and significantly associated with invasive candidiasis (p = 0.077) and patients outcome (p = 0.057).
Conclusion
Both the Candida colonization index and the Candida score with cut-off values ≥ 0.5 and ≥ 2.5 are very useful tools to select patients at high risk of developing invasive Candida infections in the medical intensive care unit setting, who would benefit from early antifungal treatment.
Zusammenfassung
Grundlagen
In den vergangenen Jahrzehnten konnte eine stetige Zunahme der Inzidenz invasiver Candida Infektionen bei schwerkranken Patienten, die an Intensivstationen aufgenommen wurden, beobachtet werden. Die Diagnose invasiver Candida Infektionen ist aber nach wie vor schwierig und wird oft erst im späteren Verlauf der Erkrankung gestellt. Bei verspätetem Beginn einer antimykotischen Therapie verschlechtert sich die Prognose dramatisch. Klinische Scoring-Systeme wie der Candida Colonization Index und der auf vier Risikofaktoren-basierte Candida Score könnten wirksame Hilfsmittel darstellen, um Patienten mit hohem Risiko für die Entwicklung invasiver Candida Infektionen zu erkennen, die von der Gabe systemischer Antimykotika profitieren könnten.
Material und Methoden
Eine prospektive, monozentrische Beobachtungsstudie wurde von Dezember 2010 bis Dezember 2011 durchgeführt. Es wurden alle Patienten über 18 Jahre eingeschlossen, die länger als 7 Tage auf einer internistischen Intensivstation aufgenommen waren. Demographische Daten, zugrundeliegende Erkrankungen, Gründe für die Aufnahme auf die Intensivstation, sowie das Vorhandensein und die Dauer von Risikofaktoren für die Kolonisierung und Infektion mit Candida Arten wurden für jeden Patienten erhoben. Die Berechnung des Candida Colonization Index und des Candida Scores erfolgte wöchentlich, bis zur Entlassung oder bis zum Tod des Patienten.
Ziele
Das Hauptziel dieser Studie war die Feststellung der Inzidenz invasiver Candida Infektionen einer internistischen Intensivstation und die Bestimmung der Korrelation invasiver Candida Infektionen mit dem Candida Colonization Index und dem Candida Score.
Ergebnisse
Insgesamt wurden 65 Patienten in die Studie eingeschlossen. Invasive Candida Infektionen wurden in 5 Patienten nachgewiesen (7,7 %): 2x Candidämie, 2x Peritonitis und 1x Pneumonie. Alle Patienten wiesen einen Candida Colonization Index ≥ 0,5 (Inzidenzrate 16,7 % [5/30]) und einen Candida score ≥ 2,5 (Inzidenzrate 29,4 % [5/17]) auf. Künstliche Beatmung (p = 0,013) sowie beide Candida Scoring-Systeme (p = 0,013 vs. p < 0,001) waren statistisch signifikant mit invasiven Candida Infektionen assoziiert. Die Mortalitätsrate war hoch (80 %). Interessanterweise konnte keine statistisch signifikante Korrelation zwischen einer Behandlung mit systemischen Antimykotika und dem Vorhandensein einer invasiven Candida Infektion (p = 0,077) sowie dem Outcome der Patienten (p = 0,057) gefunden werden.
Schlussfolgerung
Sowohl der Candida Colonization Index als auch der Candida Score mit Grenzwerten von ≥ 0,5 und ≥ 2,5 stellen sehr nützliche Hilfsmittel zur Identifizierung von Patienten mit hohem Risiko für die Entwicklung invasiver Candida Infektionen dar, die von einem frühen Beginn antimykotischer Therapie profitieren könnten.
Similar content being viewed by others
References
Hollenbach E. Invasive candidiasis in the ICU: evidence based and on the edge of evidence. Mycoses. 2008;51(Suppl 2):25–45.
Eggimann P, Bille J, Marchetti O. Diagnosis of invasive candidiasis in the ICU. Ann Intensive Care. 2011;1:37.
Kratzer C, et al. Design and use of Candida scores at the intensive care unit. Mycoses. 2011;54(6):467–74.
Leon C, et al. A bedside scoring system (“Candida score”) for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization. Critl Care Med. 2006;34(3):730–7.
Guery BP, et al. Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: Part I. Epidemiology and diagnosis. Intensive Care Med. 2009;35(1):55–62.
Ostrosky-Zeichner L, Pappas PG. Invasive candidiasis in the intensive care unit. Crit Care Med. 2006;34(3):857–63.
Ostrosky-Zeichner L. Invasive mycoses: diagnostic challenges. Am J Med. 2012;125(1 Suppl):S14–24.
Philip A, et al. Syscan3, a kit for detection of anti-Candida antibodies for diagnosis of invasive candidiasis. J Clin Microbiol. 2005;43(9):4834–5.
Pappas PG, et al. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis. 2009;48(5):503–35.
Eggimann P, Garbino J, Pittet D. Epidemiology of Candida species infections in critically ill non-immunosuppressed patients. Lancet Infect Dis. 2003;3(11):685–702.
Blumberg HM, et al. Risk factors for candidal bloodstream infections in surgical intensive care unit patients: the NEMIS prospective multicenter study. The National Epidemiology of Mycosis Survey. Clin Infect Dis. 2001;33(2):177–86.
Wey SB, et al. Risk factors for hospital-acquired candidemia. A matched case-control study. Arch Intern Med. 1989;149(10):2349–53.
Ostrosky-Zeichner L. Prophylaxis or preemptive therapy of invasive candidiasis in the intensive care unit? Crit Care Med. 2004;32(12):2552–3.
Charles PE, et al. Candida spp. colonization significance in critically ill medical patients: a prospective study. Intensive Care Med. 2005;31(3):393–400.
Pittet D. et al. Candida colonization and subsequent infections in critically ill surgical patients. Ann Surg. 1994;220(6):751–8.
Leon C, et al. Usefulness of the “Candida score” for discriminating between Candida colonization and invasive candidiasis in non-neutropenic critically ill patients: a prospective multicenter study. Crit Care Med. 2009;37(5):1624–33.
Bassetti M, et al. Epidemiological trends in nosocomial candidemia in intensive care. BMC Infect Dis. 2006;6:21.
Vincent JL, et al. Epidemiology, diagnosis and treatment of systemic Candida infection in surgical patients under intensive care. Intensive Care Med. 1998;24(3):206–16.
Marchetti O, et al. Epidemiology of candidemia in Swiss tertiary care hospitals: secular trends, 1991–2000. Clin Infect Dis. 2004;38(3):311–20.
Bassetti M, et al. Candida infections in the intensive care unit: epidemiology, risk factors and therapeutic strategies. Expert Rev Anti Infect Ther. 2006;4(5):875–85.
Rangel-Frausto MS, et al. National epidemiology of mycoses survey (NEMIS): variations in rates of bloodstream infections due to Candida species in seven surgical intensive care units and six neonatal intensive care units. Clin Infect Dis. 1999;29(2):253–8.
Kullberg BJ, et al. European expert opinion on the management of invasive candidiasis in adults. Clin Microbiol Infect. 2011;17(Suppl 5):1–12.
Jorda-Marcos R, et al. Risk factors for candidaemia in critically ill patients: a prospective surveillance study. Mycoses. 2007;50(4):302–10.
McKinnon PS, et al. Temporal assessment of Candida risk factors in the surgical intensive care unit. Arch Surg. 2001;136(12):1401–8 (discussion 1409).
Nucci M, Colombo AL. Risk factors for breakthrough candidemia. Eur J Clinl Microbiol Infect Dis. 2002;21(3):209–11.
Piazza O, et al. Candidemia in intensive care patients. Risk factors and mortality. Minerva Anestesiol. 2004;70(1–2):63–9.
Garbino J, et al. Prevention of severe Candida infections in nonneutropenic, high-risk, critically ill patients: a randomized, double-blind, placebo-controlled trial in patients treated by selective digestive decontamination. Intensive Care Med. 2002;28(12):1708–17.
Pelz RK, et al. Double-blind placebo-controlled trial of fluconazole to prevent candidal infections in critically ill surgical patients. Ann Surg. 2001;233(4):542–8.
Leroy O, et al. Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005–2006). Critical Care Med. 2009;37(5):1612–8.
Bassetti M, Mikulska M, Viscoli C. Bench-to-bedside review: therapeutic management of invasive candidiasis in the intensive care unit. Crit Care. 2010;14(6):244.
Charles PE, et al. Candidemia in critically ill patients: difference of outcome between medical and surgical patients. Intensive Care Med. 2003;29(12):2162–9.
Michalopoulos AS, Geroulanos S, Mentzelopoulos SD. Determinants of candidemia and candidemia-related death in cardiothoracic ICU patients. Chest. 2003;124(6):2244–55.
Viale P. Candida colonization and candiduria in critically ill patients in the intensive care unit. Drugs. 2009;69(Suppl 1):51–7.
Dimopoulos G, et al. Candida albicans versus non-albicans intensive care unit-acquired bloodstream infections: differences in risk factors and outcome. Anesth Analg. 2008;106(2):523–9 (table of contents).
Dubau B, Triboulet C, Winnock S. [Use of the colonization index]. Ann Fr Anesth Reanim. 2001;20(4):418–20.
Chabasse D. [Yeast count in urine. Review of the literature and preliminary results of a multicenter prospective study carried out in 15 hospital centers]. Ann Fr Anesth Reanim. 2001;20(4):400–6.
Piarroux R, et al. Assessment of preemptive treatment to prevent severe candidiasis in critically ill surgical patients. Crit Care Med. 2004;32(12):2443–9.
Normand S, et al. Oral nystatin prophylaxis of Candida spp. colonization in ventilated critically ill patients. Intensive Care Med. 2005;31(11):1508–13.
Agvald-Ohman C, et al. Invasive candidiasis in long-term patients at a multidisciplinary intensive care unit: Candida colonization index, risk factors, treatment and outcome. Scand J Infect Dis. 2008;40(2):145–53.
Senn L, et al. Caspofungin for prevention of intra-abdominal candidiasis in high-risk surgical patients. Intensive Care Med. 2009;35(5):903–8.
Eggimann P, Ostrosky-Zeichner L. Early antifungal intervention strategies in ICU patients. Current Opin Crit Care. 2010;16(5):465–9.
Caggiano G, et al. Candida colonization index in patients admitted to an ICU. Int J Mol Sci. 2011;12(10):7038–47.
Wang DH, et al. [The preemptive treatment of invasive Candida infection with reference of corrected colonization index in critically ill patients: a multicenter, prospective, randomized controlled clinical study]. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2009;21(9):525–8.
Leroy G, et al. Evaluation of “Candida score” in critically ill patients: a prospective, multicenter, observational, cohort study. Ann Intensive Care. 2011;1(1):50.
Charles PE, et al. Serum procalcitonin levels in critically ill patients colonized with Candida spp: new clues for the early recognition of invasive candidiasis? Intensive Care Med. 2009;35(12):2146–50.
Posteraro B, et al. Early diagnosis of candidemia in intensive care unit patients with sepsis: a prospective comparison of (1→3)-beta-d-glucan assay, Candida score, and colonization index. Crit Care. 2011;15(5):R249.
Eggimann P, Marchetti O. Is (1→3)-beta-d-glucan the missing link from bedside assessment to pre-emptive therapy of invasive candidiasis? Crit Care. 2011;15(6):1017.
Horn DL, et al. Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry. Clin Infect Dis, 2009;48(12):1695–703.
Marriott DJ, et al. Determinants of mortality in non-neutropenic ICU patients with candidaemia. Crit Care. 2009;13(4):R115.
Hsueh PR, et al. Consensus statement on the management of invasive candidiasis in intensive care units in the Asia-Pacific Region. Int J Antimicrob Agents. 2009;34(3):205–9.
Gudlaugsson O, et al. Attributable mortality of nosocomial candidemia, revisited. Clin Infect Dis. 2003;37(9):1172–7.
Pagano L, et al. The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study. Haematologica. 2006;91(8):1068–75.
Colombo AL, et al. Epidemiology of candidemia in Brazil: a nationwide sentinel surveillance of candidemia in eleven medical centers. J Clin Microbiol. 2006;44(8):2816–23.
Conflict of interest
The authors declare that there is no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kautzky, S., Staudinger, T. & Presterl, E. Invasive Candida infections in patients of a medical intensive care unit. Wien Klin Wochenschr 127, 132–142 (2015). https://doi.org/10.1007/s00508-014-0644-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00508-014-0644-z
Keywords
- Invasive candidiasis
- Invasive Candida infection
- Candida colonization index
- Candida score
- Intensive care unit
- Critically ill patients
- Systemic antifungal therapy